Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003

This study has been completed.
Information provided by (Responsible Party):
Catabasis Pharmaceuticals Identifier:
First received: November 6, 2012
Last updated: July 9, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)